WELLINGTON MANAGEMENT GROUP LLP

Position in ASND — Ascendis Pharma A/S

CIK 902219 Boston, MA

Back to ASND Full portfolio

Position in ASND

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$402,023,391

+$26,140,769 QoQ

Shares Held

1,757,633

-0.3% QoQ

Ownership

2.68%

of shares outstanding

% of Portfolio

0.08%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

25 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 98.41354822081743.ToString("F0")% None 1.5864517791825712.ToString("F0")%

Common Shares in ASND Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

WELLINGTON MANAGEMENT GROUP LLP holds $14,418,547,095 across 180 Biotechnology names. ASND ranks #8 (2.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	3,212,589	$1,434,549,489
2	REGN	Regeneron Pharmaceuticals, Inc.	1,837,459	$1,419,694,318
3	ARGX	Argenx SE	1,021,457	$745,918,971
4	ALNY	Alnylam Pharmaceuticals, Inc.	1,935,925	$640,539,501
5	RVMD	Revolution Medicines, Inc.	6,027,819	$586,205,394
6	CYTK	Cytokinetics Inc	8,009,489	$527,905,416
7	IONS	Ionis Pharmaceuticals Inc	6,391,816	$479,961,458
8	ASND	Ascendis Pharma A/S This page	1,757,633	$402,023,391

All Filings in ASND

Export CSV

25 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$402,023,391	1,757,633	-0.3%	Shares	Defined	2026-05-15
2025-12-31	$375,882,622	1,762,721	-2.0%	Shares	Defined	2026-02-17
2025-09-30	$357,645,467	1,798,931	+95.9%	Shares	Defined	2025-11-14
2025-06-30	$158,463,194	918,095	+56.2%	Shares	Defined	2025-08-14
2025-03-31	$91,608,737	587,763	-16.5%	Shares	Defined	2025-05-13
2024-12-31	$96,943,769	704,175	-44.2%	Shares	Defined	2025-02-12
2024-09-30	$188,351,575	1,261,480	-51.7%	Shares	Defined	2024-11-14
2024-06-30	$356,341,298	2,612,856	-4.8%	Shares	Defined	2024-08-14
2024-03-31	$415,093,466	2,745,872	-15.5%	Shares	Defined	2024-05-15
2023-12-31	$409,122,501	3,248,293	-0.9%	Shares	Defined	2024-02-12
2023-09-30	$306,874,383	3,277,172	+4.1%	Shares	Defined	2023-11-14
2023-06-30	$281,039,322	3,148,900	+7.3%	Shares	Defined	2023-08-14
2023-03-31	$314,561,174	2,933,792	-3.9%	Shares	Defined	2023-05-12
2022-12-31	$372,936,775	3,053,605	-16.8%	Shares	Defined	2023-02-13
2022-09-30	$379,194,051	3,672,226	+3.5%	Shares	Defined	2022-11-14
2022-06-30	$329,927,772	3,549,137	-23.9%	Shares	Defined	2022-08-15
2022-03-31	$547,552,347	4,665,579	+14.6%	Shares	Defined	2022-05-16
2021-12-31	$547,634,497	4,070,724	+3.2%	Shares	Defined	2022-02-11
2021-09-30	$628,832,437	3,945,244	+14.9%	Shares	Defined	2021-11-15
2021-06-30	$451,778,609	3,434,273	-1.7%	Shares	Defined	2021-08-16
2021-03-31	$450,091,874	3,492,333	+2.7%	Shares	Defined	2021-05-17
2020-12-31	$567,311,840	3,401,558	+4.6%	Shares	Defined	2021-02-12
2020-09-30	$501,811,752	3,251,761	+82.0%	Shares	Defined	2020-11-16
2020-06-30	$264,192,437	1,786,291	+7.0%	Shares	Defined	2020-08-14
2020-03-31	$188,075,138	1,670,146	—	Shares	Defined	2020-05-14
No filing history on record for this holder in this stock.